Generic Eliquis ( Apixaban )

Buy Generic Eliquis (Apixaban) without prescription in Canada

Eliquis (Apixaban 2.5 mg and 5 mg): Comprehensive Patient Information for Canada

Basic Product Information

Mechanism of Action

In simple terms: Apixaban is an anticoagulant (blood thinner) that helps prevent dangerous blood clots from forming in your body. It works by blocking a specific protein in your blood called factor Xa, which is needed for blood to clot. By blocking this protein, apixaban reduces the risk of clots that can cause strokes, heart attacks, or blockages in the lungs and legs.

For specialists: Apixaban is a reversible, direct, and highly selective inhibitor of factor Xa (FXa). It does not require antithrombin III for antithrombotic activity. Apixaban inhibits free and clot-bound FXa, as well as prothrombinase activity. By inhibiting FXa, apixaban prevents thrombin generation and thrombus development. It has no direct effects on platelet aggregation but indirectly inhibits platelet aggregation induced by thrombin.

Pharmacokinetics

• Absorption: Apixaban is rapidly absorbed, with maximum plasma concentrations (Cmax) appearing approximately 3 to 4 hours after tablet intake. The absolute bioavailability is approximately 50% for doses up to 10 mg.
• Metabolism: Apixaban is metabolized primarily by CYP3A4/5, with minor contributions from CYP1A2, 2C8, 2C9, 2C19, and 2J2. Approximately 25% of the administered dose is recovered as metabolites, with the majority found in feces.
• Elimination: Apixaban has multiple elimination routes. Total clearance is approximately 3.3 L/h.
• Half-life: The elimination half-life is approximately 12 hours.
• Duration of Action: The pharmacodynamic effect can be expected to persist for at least 24 hours after the last dose, i.e., for about two drug half-lives.

Uses in Daily Life and Best Practice Advice

Apixaban is prescribed in Canada for several conditions that require anticoagulation to prevent or treat blood clots. Your physician will determine the appropriate use and dose based on your specific medical situation.

• Typical Uses: Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); prevention of recurrent DVT and PE; and prevention of DVT and PE after elective hip or knee replacement surgery.
• Administration: Tablets are taken orally, with or without food, usually twice daily. Take the medication at the same times each day to maintain consistent blood levels.
• Monitoring: Routine laboratory coagulation monitoring is not necessary. However, periodic clinical assessment is important to reinforce compliance, review medication changes, and assess for possible drug interactions. At least yearly assessment of creatinine clearance is recommended.
• Do Not Stop Suddenly: Premature discontinuation of apixaban increases the risk of thrombotic events. Do not stop taking this medication without consulting your physician.

Morning vs. Evening Dosing

Apixaban is typically taken twice daily, approximately 12 hours apart. There is no specific recommendation for morning versus evening dosing, but it is important to maintain a consistent schedule. Some patients find it easier to take their doses with breakfast and dinner to help remember. Always follow the schedule recommended by your physician.

• Morning and Evening: Taking doses approximately 12 hours apart helps maintain steady levels of the medication in your blood.
• Consistency: Take apixaban at the same times every day to ensure maximum effectiveness.
• Missed Dose: If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time to make up for a missed dose.
• Professional Guidance: Your healthcare provider may adjust the timing based on your other medications and daily routine.

Administration With or Without Food

Apixaban can be taken with or without food. However, taking it with a meal may help reduce the chance of stomach upset. If you have difficulty swallowing tablets, ask your pharmacist about options for crushing the tablet and mixing it with water or applesauce, but only under professional guidance.

• Take apixaban with a full glass of water.
• If you take it with food, a light meal or snack is sufficient.
• Do not crush, chew, or split the tablet unless directed by your pharmacist or physician.
• If you cannot swallow the tablet whole, ask your healthcare provider for guidance on alternative administration methods.

Interaction Warnings

Indications for Apixaban

* "Off-label" means use outside the official approved indication, usually based on current medical guidelines and scientific evidence.

Dosing According to Clinical Indication

Doses should always be adjusted according to the advice of your physician and depending on your health condition. No dose adjustment is generally necessary for mild or moderate renal impairment (CrCl ≥30 mL/min). Apixaban is not recommended for patients with CrCl

Side Effects and Safety Profile

Guidelines for Correct Use

• Take apixaban exactly as prescribed by your physician. Do not change your dose without medical advice.
• Take the tablets at the same times each day, approximately 12 hours apart.
• Swallow tablets whole with water. Do not crush, chew, or split unless directed by your pharmacist.
• Do not stop taking apixaban suddenly, as this can increase your risk of blood clots.
• Keep all medical appointments, including blood tests to monitor kidney function.
• Inform every healthcare provider (including dentists, surgeons, and pharmacists) that you are taking apixaban.
• Carry a medical alert card or wear a bracelet indicating that you take an anticoagulant.
• Avoid activities that increase your risk of bleeding or injury. Use a soft toothbrush and an electric razor.
• If you are pregnant, planning to become pregnant, or breastfeeding, consult your physician. Apixaban crosses the placenta and should not be used in pregnancy or nursing mothers.
• If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose. Do not double the dose.

Alternative Treatment Options

• Rivaroxaban (Xarelto): Another direct oral anticoagulant (DOAC) that inhibits factor Xa. Taken once daily. Recent evidence suggests that apixaban is associated with a lower risk of major bleeding compared with rivaroxaban in patients with atrial fibrillation and those with venous thromboembolism.
• Dabigatran (Pradaxa): A direct thrombin inhibitor. Taken twice daily. May be an option for patients who cannot take factor Xa inhibitors.
• Edoxaban (Lixiana): A factor Xa inhibitor taken once daily. Available in Canada but may not be covered by all provincial drug plans.
• Warfarin (Coumadin): A vitamin K antagonist that requires regular INR monitoring and dietary restrictions. DOACs such as apixaban are generally preferred over warfarin due to their predictable dosing and fewer drug and food interactions.
• Low Molecular Weight Heparin (e.g., enoxaparin, dalteparin): Injectable anticoagulants that may be used when oral anticoagulants are not suitable or during pregnancy.
• Fondaparinux: An injectable factor Xa inhibitor used in some clinical situations.

Comparison: Apixaban is generally chosen for its favorable safety profile, particularly its lower risk of major bleeding compared with rivaroxaban and warfarin. It does not require routine coagulation monitoring, making it more convenient for many patients. Your physician will determine the best anticoagulant for your specific condition and health status.

Legal Status, Registration, and Coverage in Canada

• Registration: Apixaban (Eliquis) was approved by Health Canada in 2012 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for thromboprophylaxis after hip or knee replacement surgery. Subsequent approvals extended its use to the treatment and prevention of DVT and PE.
• Prescription Status: Apixaban is a prescription-only medication in Canada.
• Coverage: Apixaban is covered by many provincial and territorial drug plans, as well as private insurance plans. Coverage varies by province and by indication. Some provincial drug programs provide reimbursement for DOACs when used for post-orthopaedic surgery VTE prevention and for stroke prevention in patients with atrial fibrillation. Generic apixaban formulations are now available in Canada, which may reduce costs.
• Pharmacovigilance: Adverse reactions should be reported to Health Canada's MedEffect Canada program.

Recent Research and Clinical Guidelines (2022–2026)

• The COBRRA trial (published in 2026 in the New England Journal of Medicine) demonstrated that apixaban is safer than rivaroxaban for the treatment of acute venous thromboembolism, with significantly lower rates of clinically relevant bleeding (3.3% vs. 7.1%) during the initial three-month treatment period.
• A 2025 study from the Ottawa Hospital Research Institute found that a reduced dose of apixaban (2.5 mg twice daily) provides safer blood clot prevention in cancer patients with VTE, with no significant difference in efficacy compared with the full dose.
• Population-based studies from ICES in Ontario have shown that apixaban is associated with lower rates of major bleeding compared with rivaroxaban in older patients with atrial fibrillation, with no difference in thromboembolic events.
• Pediatric research (2026) has demonstrated that a fixed-dose-by-bodyweight-tier apixaban regimen is safe and effective for treating pediatric venous thromboembolism, though this use remains off-label in Canada.
• The SAXOPHONE trial demonstrated the safety of apixaban for thromboprophylaxis in children with heart disease.

Availability and Supply in Canada

Prices and availability may vary by province, territory, and pharmacy. Generic apixaban products are now available in Canada and may be more affordable than the brand-name Eliquis. Check with your local pharmacy for current pricing and coverage options.

Frequently Asked Questions (FAQ)

1. What is the difference between the 2.5 mg and 5 mg doses of apixaban?
   The 5 mg dose is the standard dose for most adults. The 2.5 mg dose is a reduced dose used for specific situations, such as stroke prevention in patients with certain risk factors (age ≥80 years, weight ≤60 kg, or kidney function impairment), long-term prevention of recurrent blood clots, and prevention of clots after hip or knee replacement surgery. Your physician will determine the appropriate dose for your condition.
2. Do I need regular blood tests while taking apixaban?
   Unlike warfarin, apixaban does not require routine coagulation monitoring (INR testing). However, your physician will likely check your kidney function at least once a year, and more often if you have kidney problems or other health conditions.
3. Can I drink alcohol while taking apixaban?
   Moderate alcohol consumption is generally acceptable, but excessive alcohol use can increase your risk of bleeding and should be avoided. Discuss your alcohol intake with your physician.
4. What should I do if I miss a dose of apixaban?
   If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
5. Can I stop taking apixaban if I feel fine?
   No. Do not stop taking apixaban without consulting your physician. Stopping suddenly increases your risk of developing dangerous blood clots, which can lead to stroke, heart attack, or pulmonary embolism.
6. Is apixaban safe during pregnancy?
   Apixaban crosses the placenta and should not be used during pregnancy or while breastfeeding. If you are pregnant, planning to become pregnant, or breastfeeding, consult your physician about alternative anticoagulation options.
7. What are the signs of serious bleeding I should watch for?
   Seek immediate medical attention if you experience: unusual bruising or swelling, pink/red/brown urine, black or tarry stools, coughing up blood, vomiting blood or material that looks like coffee grounds, severe headache, dizziness, weakness, or numbness. These may be signs of internal bleeding.
8. Are there generic versions of apixaban available in Canada?
   Yes. Multiple generic apixaban products are now available in Canada from manufacturers including Apotex, Sandoz, Teva, Jamp Pharma, and others. Generic versions may be more affordable than the brand-name Eliquis.